MARIA COLINA: Open Payments
NPI 1295418770 · CHALMETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$841 in 15 payments from 6 companies in 2025. Trend: 2023 $53 · 2024 $1,136 · 2025 $841
Food & beverage: $841
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $259 |
| Regeneron Healthcare Solutions, Inc. | 7 | $184 |
| GlaxoSmithKline, LLC. | 2 | $140 |
| Viatris Specialty LLC | 1 | $123 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $103 |
| GENZYME CORPORATION | 1 | $32 |
Products named: FASENRA, DUPIXENT, NUCALA, YUPELRI, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
